RT Journal Article
SR Electronic
T1 Nonpharmaceutical Interventions Remain Essential to Reducing COVID-19 Burden Even in a Well-Vaccinated Society: A Modeling Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.29.21254568
DO 10.1101/2021.03.29.21254568
A1 Tomás M. León
A1 Jason Vargo
A1 Erica S. Pan
A1 Seema Jain
A1 Priya B. Shete
YR 2021
UL http://medrxiv.org/content/early/2021/03/31/2021.03.29.21254568.abstract
AB Vaccination and non-pharmaceutical interventions (NPIs) reduce transmission of SARS-CoV-2 infection, but their effectiveness depends on coverage and adherence levels. We used scenario modeling to evaluate their effects on cases and deaths averted and herd immunity. NPIs and vaccines worked synergistically in different parts of the pandemic to reduce disease burden.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the California Department of Public Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCalifornia COVID-19 data used in this modeling study is publicly available through https://covid19.ca.gov/.